GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LENZ Therapeutics Inc (NAS:LENZ) » Definitions » Total Long-Term Liabilities

LENZ (LENZ Therapeutics) Total Long-Term Liabilities : $0.67 Mil (As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is LENZ Therapeutics Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. LENZ Therapeutics's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was $0.67 Mil.


LENZ Therapeutics Total Long-Term Liabilities Historical Data

The historical data trend for LENZ Therapeutics's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LENZ Therapeutics Total Long-Term Liabilities Chart

LENZ Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Total Long-Term Liabilities
31.30 61.62 144.57 0.81

LENZ Therapeutics Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.27 1.14 1.02 0.81 0.67

LENZ Therapeutics Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.


LENZ Therapeutics Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of LENZ Therapeutics's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


LENZ Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
201 Lomas Santa Fe Drive, Suite 300, Solana Beach, CA, USA, 92075
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.